Wednesday - April 01, 2026

Internationally Accredited Hospital BC Reinforces Global Standards of Patient Care Under the Leadership of Dr. Jalil Illan

Dr. Jalil Illan Hospital BC in Tijuana, led by Dr. Jalil Illan, continues to uphold global patient care standards with accreditation from Joint Commission International. The hospital offers advanced bariatric procedures, including gastric sleeve surgery, supported by modern facilities, strict … Continue reading

ARCALYST Sales Forecast Indicates Robust Market Expansion Through 2034 Driven by Rising Adoption in Recurrent Pericarditis and Expanding IL-1 Targeted Therapies | DelveInsight

ARCALYST Sales Forecast Kiniksa Pharmaceuticals has recently reported strong year-over-year revenue growth for ARCALYST, driven primarily by its expanding use in recurrent pericarditis. The company has intensified its efforts to increase disease awareness, engage specialists, and enhance patient access programs. … Continue reading

Hidradenitis Suppurativa Market: High-Growth Opportunities for Investors to 2036 – DelveInsight | AbbVie, Novartis, UCB Biopharma, Eli Lilly, Institut Pasteur, UCB Biopharma SRL, MoonLake Immunothera

The Key Hidradenitis Suppurativa Companies in the market include – Kymera Therapeutics, CSL Behring, Azora Therapeutics, Union Therapeutics, Eli Lilly and company, Boehringer Ingelheim, ACELYRIN, Incyte Corporation, InflaRx, Novartis, ChemoCentryx, Janssen Pharmaceutical/XBiotech, Aclaris Therapeutics, and others. DelveInsight’s “Hidradenitis Suppurativa Market … Continue reading

Projecting the Global Catheter Stabilization Devices Market Size to Expand at a 6.31% CAGR Through 2032, DelveInsight Analysis

“Catheter Stabilization Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. As per DelveInsight’s assessment, The catheter stabilization/securement device market is being driven … Continue reading

Projecting the Global Hernia Repair Devices Market Size to Expand at a 5.19% CAGR Through 2032, DelveInsight Analysis

As per DelveInsight’s assessment, The global hernia repair devices market is being driven by the increasing incidence of hernias and related risk factors, advancements in surgical technologies and products, a growing preference for minimally invasive procedures, along with several other … Continue reading

Glioblastoma Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic Therapeutics, Autotelic Therapeuti

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Glioblastoma pipeline constitutes 200+ key companies continuously working towards developing 220+ Glioblastoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The … Continue reading